Familial dysbetalipoproteinemia (FD) is a highly atherogenic, prevalent genetically based
lipid disorder. About 10% of FD patients have rare APOE variants associated with autosomal …

There are some limitations to using the body condition score (BCS) for client education to
prevent obesity, hyperlipidemia-related diseases, and orthopedic diseases in dogs because …

Patients affected by familial hypercholesterolemia possess elevated low-density lipoprotein
cholesterol and therefore have greater risk for cardiovascular disease. About 90% of familial …

Despite the implementation of next-generation sequencing-based genetic testing on
patients with clinical familial hypercholesterolemia (FH), most cases lack complete genetic …

Background: Familial hypercholesterolemia (FH) comprises high LDL-cholesterol (LDL-c)
levels and high cardiovascular disease risk. In the absence of pathogenic variants in …

Background and Objectives: Familial hypercholesterolemia (FH) is a genetic disease that is
massively underdiagnosed worldwide. Affected patients are at high risk of cardiovascular …

Familial hypercholesterolaemia (FH) causes cardiovascular disease from a young age, due
to extremely high plasma concentrations of LDL-cholesterol. This thesis examines (1) the …

1. Introduction: Patients with Alirocumab resistance has not been confirmed in the current
literature. 1.2. Case Report: We reported case of Alirocumab resistance with CAD and …